Clinical Trial Update: Single Immediate Instillation of EO9 After TURBT in Patients With Non-muscle-invasive Bladder Cancer (NMIBC) [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 trial evaluating a single immediate instillation of EO9 after TURBT in non-muscle-invasive bladder cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• EO9

Snippet

Sponsor: Nippon Kayaku Co., Ltd. | Conditions: Bladder Cancer | Phase 2, Phase 3 | Status: TERMINATED